Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

IgM and IgG Immunoreactivity of SARS-CoV-2 Recombinant M Protein
Zorana Lopandić, Isidora Protić-Rosić, Aleksandra Todorović, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 9, pp. 4951-4951
Open Access | Times Cited: 28

Showing 1-25 of 28 citing articles:

Diagnostics and analysis of SARS-CoV-2: current status, recent advances, challenges and perspectives
Tao Dong, Mingyang Wang, Junchong Liu, et al.
Chemical Science (2023) Vol. 14, Iss. 23, pp. 6149-6206
Open Access | Times Cited: 31
Peptide microarrays coupled to machine learning reveal individual epitopes from human antibody responses with neutralizing capabilities against SARS-CoV-2
Sven‐Kevin Hotop, Susanne Reimering, Aditya Shekhar, et al.
Emerging Microbes & Infections (2022) Vol. 11, Iss. 1, pp. 1037-1048
Open Access | Times Cited: 25
Major role of S-glycoprotein in providing immunogenicity and protective immunity in mRNA lipid nanoparticle vaccines based on SARS-CoV-2 structural proteins
Evgeniia N. Bykonia, Denis A. Kleymenov, Vladimir А. Gushchin, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 2
SARS-CoV-2 membrane protein-specific antibodies from critically ill SARS-CoV-2–infected individuals interact with Fc receptor–expressing cells but do not neutralize the virus
Daniel Fernández-Soto, Paula Alexandra Reis Bueno, Urtzi Garaigorta, et al.
Journal of Leukocyte Biology (2024) Vol. 115, Iss. 5, pp. 985-991
Open Access | Times Cited: 2
Anti-membrane Antibodies Persist at Least One Year and Discriminate Between Past Coronavirus Disease 2019 Infection and Vaccination
Maya F. Amjadi, Ryan R. Adyniec, Srishti Gupta, et al.
The Journal of Infectious Diseases (2022) Vol. 226, Iss. 11, pp. 1897-1902
Open Access | Times Cited: 14
An Adjuvanted Inactivated SARS-CoV-2 Microparticulate Vaccine Delivered Using Microneedles Induces a Robust Immune Response in Vaccinated Mice
Sharon Vijayanand, Smital Patil, Ipshita Menon, et al.
Pharmaceutics (2023) Vol. 15, Iss. 3, pp. 895-895
Open Access | Times Cited: 7
PRAK-03202: A triple antigen virus-like particle vaccine candidate against SARS CoV-2
Saumyabrata Mazumder, Ruchir Rastogi, Avinash Undale, et al.
Heliyon (2021) Vol. 7, Iss. 10, pp. e08124-e08124
Open Access | Times Cited: 17
Application of Baculovirus Expression Vector system (BEV) for COVID-19 diagnostics and therapeutics: a review
Muhammad Azharuddin Azali, Salmah Mohamed, Azian Harun, et al.
Journal of Genetic Engineering and Biotechnology (2022) Vol. 20, Iss. 1, pp. 98-98
Open Access | Times Cited: 9
Post-COVID Endocrine Disorders: Putative Role of Molecular Mimicry and Some Pathomorphological Correlates
Muslimbek G. Normatov, В. Е. Карев, А. В. Колобов, et al.
Diagnostics (2023) Vol. 13, Iss. 3, pp. 522-522
Open Access | Times Cited: 5
Major Role of S-Glycoprotein in Providing Immunogenicity and Protective Immunity in mRNA Lipid Nanoparticle Vaccines Based on SARS-CoV-2 Structural Proteins
Evgeniia N. Bykonia, Denis A. Kleymenov, Vladimir А. Gushchin, et al.
Vaccines (2024) Vol. 12, Iss. 4, pp. 379-379
Open Access | Times Cited: 1
Genomic characterization and molecular evolution of SARS-CoV-2 in Rio Grande do Sul State, Brazil
Amanda de Menezes Mayer, Patrícia Aline Gröhs Ferrareze, Luiz Felipe Valter de Oliveira, et al.
Virology (2023) Vol. 582, pp. 1-11
Open Access | Times Cited: 4
Therapeutic significance of nano- and biosensor technology in combating SARS-CoV-2: a review
Rameesha Abid, Muhammad Khurram Shahzad, Samra Muhammad Sulaman, et al.
Applied Nanoscience (2022) Vol. 12, Iss. 11, pp. 3127-3140
Open Access | Times Cited: 5
Preparation and pre-clinical evaluation of flagellin-adjuvanted NOM vaccine candidate formulated with Spike protein against SARS-CoV-2 in mouse model
Narges Farshidi, Tayebeh Ghaedi, Mehdi Hassaniazad, et al.
Microbial Pathogenesis (2022) Vol. 171, pp. 105736-105736
Open Access | Times Cited: 5
Detection of IgA and IgG Antibodies against the Structural Proteins of SARS-CoV-2 in Breast Milk and Serum Samples Derived from Breastfeeding Mothers
Karen Cortés-Sarabia, Vianey Guzman-Silva, Karla Montserrat Martinez-Pacheco, et al.
Viruses (2023) Vol. 15, Iss. 4, pp. 966-966
Open Access | Times Cited: 2
Peptide microarray analysis of in-silico predicted B-cell epitopes in SARS-CoV-2 sero-positive healthcare workers in Bulawayo, Zimbabwe
Arthur Vengesai, Tricia Naicker, Herald Midzi, et al.
Acta Tropica (2022) Vol. 238, pp. 106781-106781
Open Access | Times Cited: 4
Prevalence of SARS-CoV-2-specific antibodies in a sample of the Lithuanian population-based study in Spring 2023
Martynas Simanavičius, Indrė Kučinskaitė-Kodzė, Snieguolė Kaselienė, et al.
Heliyon (2024) Vol. 10, Iss. 8, pp. e29343-e29343
Open Access
Development and characterization of monoclonal antibodies recognizing nucleocapsid protein of multiple SARS-CoV-2 variants
Hongyu Qiu, Xin-Yong Yuan, Kimberly Holloway, et al.
Heliyon (2024) Vol. 10, Iss. 15, pp. e35325-e35325
Open Access
Coronavirus spike protein-based vaccines. Vaccine delivery systems
Akmal M. Asrorov, Mirzakamol S. Ayubov, Bin Tu, et al.
Medicine in Drug Discovery (2024), pp. 100198-100198
Open Access
M protein ectodomain-specific immunity restrains SARS-CoV-2 variants replication
Yibo Tang, Kaiming Tang, Yunqi Hu, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access
Evaluation of S- and M-Proteins Expressed in Escherichia coli and HEK Cells for Serological Detection of Antibodies in Response to SARS-CoV-2 Infections and mRNA-Based Vaccinations
Mandy Schwarze, Ji Luo, Alexandra Brakel, et al.
Pathogens (2022) Vol. 11, Iss. 12, pp. 1515-1515
Open Access | Times Cited: 3
Anti-membrane and anti-spike antibodies are long-lasting and together discriminate between past COVID-19 infection and vaccination
Maya F. Amjadi, Ryan R. Adyniec, Srishti Gupta, et al.
medRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 4
Detection of humoral and cellular immune response to anti-SARS-CoV-2 BNT162b2 vaccine in breastfeeding women and naïve and previously infected individuals
Milena Čavić, Andrijana Nešić, Katarina Mirjačić Martinović, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 1
A new multi-epitope vaccine candidate based on S and M proteins is effective in inducing humoral and cellular immune responses against SARS-CoV-2 variants: an in silico design approach
Amir Samimi Hashjin, Souroush Sardari, Mosayeb Rostamian, et al.
Journal of Biomolecular Structure and Dynamics (2023) Vol. 42, Iss. 22, pp. 12505-12522
Closed Access | Times Cited: 1
A six-month study of anti-SARS-CoV-2 BNT162b2 mRNA vaccination: A comparative analysis of essential trace elements and anti-RBD IgG sera levels
Andrijana Nešić, Aleksandar Stojsavljević, Jovana Jagodić, et al.
Journal of Trace Elements in Medicine and Biology (2022) Vol. 74, pp. 127079-127079
Open Access | Times Cited: 2
Post-COVID Endocrine Disorders: Putative Role of Molecular Mimicry and Some Pathomorphological Correlates
Muslimbek G. Normatov, В. Е. Карев, А. В. Колобов, et al.
(2022)
Open Access | Times Cited: 1
Page 1 - Next Page

Scroll to top